Literature DB >> 19357540

Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.

Heidi C Roberts1, Demetris A Patsios, Narinder S Paul, Marc DePerrot, Warren Teel, Hamid Bayanati, Frances Shepherd, Michael R Johnston.   

Abstract

PURPOSE: We established a screening program for prior asbestos workers using low-dose computed tomography (LDCT).
METHODS: Between March 2005 and October 2007 we performed LDCT (50-60 mA, 120 kV, 1.25 mm) in 516 asbestos-exposed individuals. Parenchymal nodules were followed according to lung cancer screening recommendations, morphology and location of pleural plaques was noted in detail.
RESULTS: We included 507 men and 9 women (median 60.0 years), 395 (76.6%) were smokers. Annual repeat has been performed in 356 participants. We found plaques in 357 subjects (69.2%), commonly calcified (79.6%), flat (86.6%), and symmetric (86.8%), and mostly involving the costal (96.4%) and diaphragmatic (81.8%) pleura. Uncommon plaques were lobulated (13.2%), right-dominant asymmetric (4.5%), or with effusions (0.1%).We found pulmonary nodules in 371 subjects (71.9%), 91 (17.6%) had at least one nodule > or =5 mm; 10 growing nodules were found on annual repeat LDCT. In 41 individuals, plaques were regarded as atypical; three had new pleural/peritoneal abnormalities on annual repeat LDCT. An interim limited computed tomography of the observed abnormality prompted 10 diagnostic biopsies, resulting in a diagnosis of six lung cancers, two pleural mesothelioma and two peritoneal mesothelioma; overall rate of screen-detected malignancies is 2.1%. There were four interval cancers, diagnosed after baseline (n = 1) or after the annual repeat (n = 3): two pleural and one peritoneal mesothelioma, and one mixed squamous/small cell carcinoma.
CONCLUSION: Screening prior asbestos workers detects advanced malignant pleural mesothelioma and early as well as late stage lung cancer. We expect to learn more about the appearance of "early mesothelioma" with continued screening.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357540     DOI: 10.1097/JTO.0b013e31819f2e0e

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  15 in total

Review 1.  [Asbestos-related diseases of the thorax].

Authors:  H-G Hieckel; K G Hering
Journal:  Radiologe       Date:  2010-07       Impact factor: 0.635

2.  Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Authors:  Harvey I Pass; Stephen M Levin; Michael R Harbut; Jonathan Melamed; Luis Chiriboga; Jessica Donington; Margaret Huflejt; Michele Carbone; David Chia; Lee Goodglick; Gary E Goodman; Mark D Thornquist; Geoffrey Liu; Marc de Perrot; Ming-Sound Tsao; Chandra Goparaju
Journal:  N Engl J Med       Date:  2012-10-11       Impact factor: 91.245

3.  Pulmonary nodules detected by thoracic computed tomography scan after exposure to asbestos: diagnostic significance.

Authors:  B Clin; A Luc; F Morlais; C Paris; J Ameille; P Brochard; J De Girolamo; A Gislard; F Laurent; M Letourneux; E Schorle; G Launoy; J-C Pairon
Journal:  Int J Tuberc Lung Dis       Date:  2011-12       Impact factor: 2.373

Review 4.  Imaging of malignant pleural mesothelioma: it is possible a screening or early diagnosis program?-a systematic review about the use of screening programs in a population of asbestos exposed workers.

Authors:  Fabio Falaschi; Chiara Romei; Sara Fiorini; Marco Lucchi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 5.  Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literature.

Authors:  David N Weissman
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

6.  A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma.

Authors:  Bill T V Duong; Licun Wu; Brenda J Green; Fatemeh Bavaghar-Zaeimi; Zongjie Wang; Mahmoud Labib; Yuxiao Zhou; Fernando J P Cantu; Thurgaa Jeganathan; Sandra Popescu; Jennifer Pantea; Marc de Perrot; Shana O Kelley
Journal:  EBioMedicine       Date:  2020-10-09       Impact factor: 8.143

Review 7.  Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.

Authors:  Seiki Hasegawa; Nobuyuki Kondo; Seiji Matsumoto; Teruhisa Takuwa; Masaki Hashimoto; Hayato Orui; Shunichi Fukuda; Kazue Yoneda; Yoshitomo Okumura; Noriaki Tsubota; Kazuya Fukuoka; Ikuko Torii; Tohru Tsujimura; Takashi Nakano
Journal:  Int J Clin Oncol       Date:  2012-01-12       Impact factor: 3.402

8.  Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.

Authors:  Michael K Felten; Khaled Khatab; Lars Knoll; Thomas Schettgen; Hendrik Müller-Berndorff; Thomas Kraus
Journal:  Int Arch Occup Environ Health       Date:  2013-02-20       Impact factor: 3.015

Review 9.  [Early recognition of lung cancer in workers occupationally exposed to asbestos].

Authors:  K Hofmann-Preiß; B Rehbock
Journal:  Radiologe       Date:  2016-09       Impact factor: 0.635

Review 10.  Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.

Authors:  Volker Neumann; Stefan Löseke; Dennis Nowak; Felix J F Herth; Andrea Tannapfel
Journal:  Dtsch Arztebl Int       Date:  2013-05-03       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.